Back to search

Article

Designing Insulin Analogues with Lower Binding Affinity to Insulin Receptor than That of Insulin Icodec

2024-04-29

Abstract excerpt

Insulin therapy is a cornerstone in the management of diabetes, yet the pursuit of optimizing its pharmacokinetic profile remains a focal point in diabetes research. For instance, insulin icodec of Novo Nordisk is a novel long-acting insulin analogue that exhibits an extended duration of action, providing a promising once-weekly treatment option for diabetic patients. However, designing insulin analogues with lowe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ddde9cb0-6c98-5387-8cd9-506c3070dddf
DOI
10.20944/preprints202404.1922.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Designing Insulin Analogues with Lower Binding Affinity to Insulin Receptor than That of Insulin IcodecDOI 10.20944/preprints202404.1922.v1
Select a neighboring publication to make it the new centre.